Mid-esophageal ulceration and candidiasis-associated distal esophagitis as two distinct clinical patterns of tetracycline or doxycycline-induced esophageal injury

Journal of Clinical Gastroenterology

Volumn 38, Issue 6, 2004, Pages 484-489

  Gencosmanoglu, Rasim ^a   Kurtkaya Yapicier, Ozlem ^c   Tiftikci, Arzu ^a,b   Avsar, Erol ^a,b   Tozun, Nurdan ^a,b   Oran, Ebru Sen ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c NONE

Author keywords

Candidiasis; Distal esophagitis; Drug induced esophageal injury; Esophageal ulceration; Tetracycline

Indexed keywords

DOXYCYCLINE; LIDOCAINE; MIDAZOLAM; MIDAZOLAM MALEATE; TETRACYCLINE;

ACNE; ADULT; AGED; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS INJURY; ESOPHAGUS ULCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NONSPECIFIC URETHRITIS; PATHOGENESIS; PRIORITY JOURNAL; TOOTH INFECTION; TREATMENT INDICATION; VAGINITIS;

ADULT; AGE DISTRIBUTION; AGED; BIOPSY, NEEDLE; CANDIDIASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; ESOPHAGITIS; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TETRACYCLINE;

EID: 3042658391     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000129058.69524.90     Document Type: Article

References (26)

1. Pemberton J. Oesophageal obstruction and ulceration caused by oral potassium therapy. Br Heart J. 1970;32:267-268.
2. Jaspersen D. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention, and management. Drug Saf. 2000;22:237-249.
3. Eng J, Sabanathan S. Drug-induced esophagitis. Am J Gastroenterol. 1991;86:1127-1133.
4. Duggar BM. Aureomycin: produce of continuing search for new antibiotics. Ann NY Acad Sc. 1948;51:177-181.
5. Shetty AK. Tetracyclines in pediatrics revisited. Clin Pediatr. 2002;41: 203-209.
6. Williams DN. Tetracyclines. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. 2nd ed. Philadelphia: WB Saunders; 1998:227-231.
7. Morris TJ, Davis TP. Doxycycline-induced esophageal ulceration in the U.S. Military service. Mil Med. 2000;165:316-319.
8. Champel V, Jonville-Bera AP, Bera F, et al. Esophageal involvement after tetracycline ingestion Therapie. 1997;52:587-589.
9. Kikendall JW, Friedman AC, Oyewole MA, et al. Pill-induced esophageal injury. Case reports and review of the medical literature. Dig Dis Sci. 1983;28:174-182.
10. Wallman IS, Hilton HB. Teeth pigmentation by tetracycline. Lancet. 1962;1:827.
11. Cohlan SQ, Bevelander G, Tiamsic T. Growth inhibition of prematures receiving tetracyclines. AJDC. 1963; 105:453.
12. Layton AM, Cunliffe WJ. Phototoxic eruptions due to doxycycline: a dose-related phenomenon. Clin Exp Dermatol. 1993;18:425-427.
13. Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol. 1997; 133:1224-1230.
14. Vazquez JA, Sobel JD. Mucosal candidiasis. Infect Dis Clin North Am. 2002;16:793-820.
15. Creteur V, Laufer I, Kressel HY, et al. Drug-induced esophagitis detected by double-contrast radiography. Radiology. 1983;147:365-368.
16. Amendola MA, Spera TD. Doxycycline-induced esophagitis. JAMA. 1985;253:1009-1011.
17. Isler M. Doxycycline-induced esophageal ulceration. Mil Med. 2001; 166: 203.
18. Crowson TD, Head LH, Ferrante WA. Esophageal ulcers associated with tetracycline therapy. JAMA. 1976;235:2747-2748.
19. O'Meara TF. A new endoscopic finding of tetracycline-induced esophageal ulcers. Gastrointest Endosc. 1980;26:106-107.
20. Biller JA, Flores A, Buie T, et al. Tetracycline-induced esophagitis in adolescent patients. J Pediatr. 1992; 120:144-145.
21. Alvares JF, Kulkami SG, Bhatia SJ, et al. Prospective evaluation of medication-induced esophageal injury and its relation to esophageal function. Indian J Gastroenterol. 1999;18:115-117.
22. Evans KT, Roberts GM. Where do all the tablets go? Lancet. 1976;2: 1237-1239.
23. Fisher RS, Malmud LS, Applegate G, et al. Effect of bolus composition on esophageal transit: concise communication. J Nucl Med. 1982;23:878-882.
24. Hey H, Jorgensen F, Sorensen K, et al. Oesophageal transit of six commonly used tablets and capsules. Br Med J. 1982;285:1717-1719.
25. Bott S, Prakash C, McCallum RW. Medication-induced esophageal injury: survey of the literature. Am J Gastroenterol. 1987;82:758-763.
26. Doman DB, Ginsberg AL. The hazard of drug-induced esophagitis. Hosp Pract. 1981;16:17-25.